- RockEDU Home >
- Podcasts & Webinars >
- Data for the People
Data for the People
Data for the People (D4P) is a web-series that invites all people to engage with relevant scientific research topics, presented by scientists from our communities. Information is sourced directly from primary scientific literature and explored in a way that maintains the rigor of the research while eliminating inaccessible jargon.
OR WATCH ON
Covid 19: Learning from a Global Pandemic
Despite it’s devastating global impact, SARS-CoV-2 has helped to shift how we think about science and society. Who could have imagined that scientific acronyms like mRNA and PCR would enter into the mainstream lexicon? COVID-19 provided an opportunity for communities to join together in pursuit of life-saving knowledge, and allowed us to deepen our relationships with one another in ways that would have been unimaginable in the “before.” Here you can get to know about our experiences building D4P in response to our sudden shift into a pandemic context.
S01 | Ep 01 40:00
Testing for COVID-19 Immunity
What you need to know COVID-19 is a disease that is caused by a member of the coronavirus family, SARS-CoV-2. Healthy human immune systems will produce a large amount of a specific antibody that can neutralize the SARS-CoV-2 virus. If scientists can detect these antibodies in a person’s blood, it means they have “beat” the virus ...
S01 | Ep 02 37:15
Can Surgical Masks Prevent Viral Spread?
What you need to know In this report, the authors designed a set of experiments to determine how well different respiratory viruses can pass through a surgical mask. (Note: This study is specific to a Kimberly Clark brand surgical mask, and does not apply to homemade, cloth-based masks.) This paper summarizes data collected between 2013 and ...
S01 | Ep 03 35:00
Tracing the Origins of SARS-CoV-2
What you need to know Since the beginning of the COVID-19 global pandemic, many conspiracies around the origins of the SARS-CoV-2 have arisen. To help assuage these concerns, scientists from multiple institutions across the globe came together to synthesize all of the genomic data that is currently available for the new coronavirus, and how it ...
S01 | Ep 04 46:22
Repurposing Existing Medicines for COVID-19
What you need to know The process of bringing a new drug into the market is long and costly (on the order of 12-14 years, and at a cost of over $2B). This has a lot to do with the numerous layers of testing required to ensure that a drug is both safe for people ...
S01 | Ep 05 40:39
Exploring the Possibilities of Reinfection
What you need to know COVID-19 is reshaping our lives. The way in which humanity moves forward from this period of time will be dictated, at least in part, by knowing what the possibilities are for reinfection. However, there are several challenges in designing experiments to answer our questions around reinfection, first and foremost being ...
S01 | Ep 06 36:29
Modeling, Math, and Social Mixing
What you need to know The following are the key terms defined in this D4P presentation, and are important for understanding the data presented. Latent and Infectious Periods. Picture the exact moment that someone becomes infected with a virus. It will take some time for the virus to enter their cells and to increase in numbers. While the ...
S01 | Ep 07 37:00
Exploring the Immune Response in Patients with COVID-19
What you need to know Information is power, and when it comes to the COVID-19 pandemic, that information must come in the form of testing! The current approach to learning about an existing infection involves looking for the presence of SARS-CoV-2 RNA via a technique called RT-PCR (described in this previous D4P talk). While this approach ...
S01 | Ep 08 46:42
Insights on Treating Diabetic Patients with COVID-19
What you need to know At the time of this D4P presentation, there have been nearly 7 million reported cases of COVID-19 worldwide. The scientific and medical communities have been working around the clock to understand how different contexts can influence the recovery of patients with COVID-19 . Early on, it became clear that pre-existing ...